Patients who have not been able to lose weight through advice and self-care may be eligible for Tier 2 Weight Management Services.
These options vary across the region and local pathways are subject to change.
Patients must complete a Tier 2 Weight Management process before consideration of referral to Tier 3 & 4 Weight Management services unless BMI is 50 or over in which case direct referral to Tier 3 & 4 Service is allowable.
The NHS Digital Weight Management Programme supports adults living with obesity who also have a diagnosis of diabetes or hypertension or both, to manage their weight and improve their health.
For those patients who are eligible to access and who successfully complete it, this 12-week online programme forms part of the Tier 2 Weight Management pathway.
Full details for local adult services can be found on the following pages:
Tier 2 Weight Management Services - Bristol (DRAFT)
Tier 2 Weight Management Services - North Somerset (DRAFT)
Tier 2 Weight Management Services - South Glos (DRAFT)
To find additional services within BNSSG please use your MiDoS Login:
Login - MiDoS Admin - 2019 (midosweb.co.uk)
If you need your password resent, or be issued with one, please contact: Dosteam.southwest@nhs.net
Weight Management - Tirzepatide (Mounjaro) - for updates on prescribing in primary care.
Exercise on Referral -in the self care section of Remedy
Policy for Weight Management Service – Tiers 3 and 4 – including Support & Obesity related surgery)
Overview | Overweight and obesity management | Guidance | NICE
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.